Morten Kruse Sørensen, Novo Nordisk, Florent Edouard, Grünenthal Group, Huw Jenkins, Veeva, Kasper Jerlang, LEO Pharma
In today’s digital world it is increasingly hard for pharmaceutical companies to successfully differentiate new brands based on their target product profile alone.
Instead, the key factor now is often the quality of customer engagement, which more and more healthcare professionals (HCPs) appear to value.
It’s enabled by a multichannel marketing (MCM) approach, but traditional MCM strategies require a much higher level of content than pharma is used to producing and approving – the answer to this is a modular approach.
Such modular content allows pharma to meet HCPs’ information demands by leveraging content assets across multiple channels and in many different combinations, at the same time providing superior targeting and tracking.
This pharmaphorum webinar, held in association with Anthill, will take place on Tuesday 17 March from 13:00 to 14:00 (GMT)/14:00 to 15:00 (CET) and will look at how the use of modular content in pharma can ease some digital worries.
Our expert panel will discuss:
•The most common challenges in the digital content creation process
•Aligning content creation tactics with the multichannel marketing strategy
•How to activate your existing content to maximise existing resource for the greatest HCP reach
•Making the customer experience a key differentiator
•Morten Kruse Sørensen, Global Director Multichannel Excellence and Operations, Novo Nordisk
•Florent Edouard, SVP, Global Head of Commercial Excellence, Grünenthal Group
•Huw Jenkins, Director, DAM Strategy, Veeva
•Kasper Jerlang, Head of Global Digital Marketing and Engagement, LEO Pharma
•Tor Kristensen, CTO, Anthill Agency
•Dominic Tyer, Creative and Editorial Director, pharmaphorum [moderator]